Eye lens dosimetry in Canadian CANDU nuclear power plants based on operational dosimetric quantities Hp(10) and Hp(0.07).

In this article, we present a methodology for performing eye lens dosimetry in CANDU nuclear power plants using an existing and highly accurate Harshaw 4-element TLD-700 dosemeter. This dosemeter, which has been specially designed for Ontario Power Generation (OPG) and Bruce Power (BP), measures the deep and shallow personal dose equivalent quantities Hp(10) and Hp(0.07), respectively. Using these measured personal dose equivalent quantities and applying a beta-ray strength scaling factor to the Hp(0.07) measurement in particular, we have developed an algorithm that can be used to calculate the dose to the lens of the eye in mixed beta-gamma fields. This scaling factor has been developed and is primarily based on results obtained from extensive collaborative study, performed by Ontario Power Generation (OPG), Bruce Power (BP) and McMaster University, through Candu Owners Group (COG) support (Bohra et al., 2021; Laranjeiro et al., 2020). Furthermore, scaling factor F, also includes effects of protective glass eyewear and results from Whole body dosimetry intercomparison exercises. The algorithm to calculate eye lens dose at CANDU power plants has been developed, based on this scaling factor and operational dosimetric quantities Hp(10) and Hp(0.07).

Quantification of pure beta spectra in mixed beta gamma fields as part of eye lens dosimetry at CANDU power plants.

To address the issue of eye lens dosimetry in nuclear industry, we initiated the project to quantify the beta and gamma-ray source term in CANDU power plants and to convert this source term into dosimetric quantities of interest, such as eye lens dose and personal dose equivalents Hp(10), Hp(0.07). This way, the eye lens dose can be compared with dosimetric operational quantities to evaluate whether independent dosimetry is required for eye lens protection, or present dosimetry is adequate.

CHARACTERIZATION OF A LANTHANUM BROMIDE DETECTOR FOR EYE LENS DOSIMETRY AT THE CANDU NUCLEAR POWER PLANTS BASED ON DIRECT MEASUREMENTS OF THE GAMMA-RAY SPECTRA.

Gamma-ray spectra were measured using a LaBr$_{3}$(Ce) spectrometer during the outage periods, aiming at quantifying the gamma source term of radiation workers' exposure, at the CANDU nuclear power reactors, for the purposes of eye lens dosimetry. The spectra were measured inside the boiler rooms, of the Bruce Power and Ontario Power Generation (OPG) CANDU nuclear power plants, where workers are exposed to relatively high dose rates radiation fields during the maintenance work. Prior to measurements at the CANDU reactors, the pulse shaping parameters of the gamma spectrometer were optimised for high rates gamma fields, up to an input rates of 120 kcps, in order to accomplish a high output rate with a reasonable energy resolution. In parallel, the response of the LaBr$_{3}$(Ce) detector was characterized by experiments and Monte Carlo simulations. The gamma spectra measured at the CANDU reactors were reported in terms of the gamma-ray fluence rate spectrum. In all measured data, $^{60}$Co and $^{95}$Nb were main contributors of the gamma fields. The measured spectra have been used to calculate the dosimetric quantities of interest: personal dose equivalents H$_{p}$(10) and H$_{p}$(0.07) and eye lens absorbed dose.

NEUDOSE: A CubeSat Mission for Dosimetry of Charged Particles and Neutrons in Low-Earth Orbit.

During space missions, astronauts are exposed to a stream of energetic and highly ionizing radiation particles that can suppress immune system function, increase cancer risks and even induce acute radiation syndrome if the exposure is large enough. As human exploration goals shift from missions in low-Earth orbit (LEO) to long-duration interplanetary missions, radiation protection remains one of the key technological issues that must be resolved. In this work, we introduce the NEUtron DOSimetry & Exploration (NEUDOSE) CubeSat mission, which will provide new measurements of dose and space radiation quality factors to improve the accuracy of cancer risk projections for current and future space missions. The primary objective of the NEUDOSE CubeSat is to map the in situ lineal energy spectra produced by charged particles and neutrons in LEO where most of the preparatory activities for future interplanetary missions are currently taking place. To perform these measurements, the NEUDOSE CubeSat is equipped with the Charged & Neutral Particle Tissue Equivalent Proportional Counter (CNP-TEPC), an advanced radiation monitoring instrument that uses active coincidence techniques to separate the interactions of charged particles and neutrons in real time. The NEUDOSE CubeSat, currently under development at McMaster University, provides a modern approach to test the CNP-TEPC instrument directly in the unique environment of outer space while simultaneously collecting new georeferenced lineal energy spectra of the radiation environment in LEO.